- Home
- ROC vs BSEM Comparison
ROC vs BSEM Comparison
Compare ROC & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROC | BSEM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.6M | 76.9M |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ROC | BSEM |
|---|---|---|
| Price | $4.05 | $3.11 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | 22.0K | ★ 133.7K |
| Earning Date | 08-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,979,679.00 | N/A |
| Revenue This Year | $29.57 | N/A |
| Revenue Next Year | $104.55 | $87.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.90 | N/A |
| 52 Week Low | $3.71 | $2.25 |
| 52 Week High | $7.80 | $5.44 |
Technical Indicators
Market Signals| Indicator | ROC | BSEM |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 37.31 |
| Support Level | $3.71 | $2.25 |
| Resistance Level | $4.59 | $4.12 |
| Average True Range (ATR) | 0.25 | 0.50 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 4.23 | 6.97 |
Price Performance
Historical ComparisonAbout ROC Rank One Computing Corporation Common stock
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.
About BSEM BioStem Technologies Inc. Common Stock
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.